文献速递心胸血管麻醉区域麻醉与超声疼痛医学

连续浅层胸骨旁肋间平面阻滞在正中开胸心脏手术中的镇痛效果:随机对照试验

Analgesic efficacy of continuous superficial parasternal intercostal plane blockade in patients undergoing cardiac surgery with median sternotomy: a randomized controlled trial.
PubMed 文献 · Reg Anesth Pain Med · 2025-11-26

主要结局24小时咳嗽时胸骨痛NRS评分两组无差异,调整后均数差-0.2(95%CI -1.7至1.3;p=0.79),次要结局亦无差异。

要点

  • 连续SPIP阻滞在24小时咳嗽胸骨痛方面未优于单次SPIP阻滞。
  • 两组均使用双侧SPIP导管,干预组输注罗哌卡因0.2%,对照组输注生理盐水。
  • 干预组1例疑似局麻药全身毒性需揭盲,无其他重大并发症。

核心结论

  • 连续SPIP阻滞在减少心脏手术后24小时咳嗽时急性胸骨痛方面未显示优于单次SPIP阻滞。

研究设计与样本

  • 在加拿大温哥华三级医疗中心进行的随机对照平行臂优越性试验。
  • 两组均置入双侧SPIP导管,每侧先给予罗哌卡因0.2% 20 mL推注,随后48小时输注研究溶液(干预组罗哌卡因0.2%,对照组生理盐水)3 mL/小时。
  • 所有患者接受标准化多模式镇痛,患者、医护人员、结局收集者和数据分析者均设盲。

主要发现

  • 24小时咳嗽时胸骨痛NRS评分:干预组均值(SD)4.0(2.2),对照组3.9(2.2)。
  • 调整后均数差-0.2(95%CI -1.7至1.3;p=0.79)。
  • 次要结局包括48小时内胸骨痛、阿片类药物使用、恢复质量、术后恶心呕吐和慢性胸骨痛,两组间无差异。
  • 干预组1例疑似局麻药全身毒性需揭盲,未记录其他重大并发症。

临床怎么用

  • 对于正中开胸心脏手术患者,连续SPIP阻滞并未比单次SPIP阻滞提供更优的24小时咳嗽痛控制。
  • 临床选择镇痛方案时需权衡连续导管带来的额外成本与风险,因其未显示额外获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Single-injection superficial parasternal intercostal plane (SPIP) blockade provides an effective and low-risk analgesic option for patients undergoing cardiac surgery with sternotomy, but their duration is limited. We sought to evaluate whether continuous SPIP blockade, compared with single-injection SPIP blockade, reduces acute sternal pain on coughing at 24 hours after cardiac surgery. METHODS: We conducted a randomized controlled parallel-arm superiority trial at a tertiary care center in Vancouver, BC, Canada. We included English-speaking adult patients undergoing scheduled cardiac surgery with full median sternotomy. We randomized participants in a 1:1 ratio to intervention or control groups, stratified by sex, using permuted block randomization with variable block sizes of 4 or 6. Patients in both study groups received bilateral SPIP catheters, with a 20 mL bolus of ropivacaine 0.2% through each catheter followed by a 3 mL/hour infusion of study solution (ropivacaine 0.2% in the intervention group and normal saline in the control group) for 48 hours. All patients received standardized multimodal analgesia. The primary outcome was the numeric rating scale (NRS) sternal pain score on standardized coughing at 24 hours. Secondary outcomes included sternal pain within 48 hours, opioid use, quality of recovery, postoperative nausea or vomiting and chronic sternal pain. Patients, healthcare providers, outcome collectors and data analysts were blinded to group allocation. RESULTS: Eighty patients were randomized (n=40 per group). Mean (SD) sternal pain (NRS) scores on coughing at 24 hours were 4.0 (2.2) in the intervention group versus 3.9 (2.2) in the control group. The adjusted mean difference was -0.2 (95% CI -1.7 to 1.3; p=0.79). There were no differences between the groups in secondary outcomes. One patient in the intervention group experienced suspected local anesthetic systemic toxicity requiring unblinding. No other major complications were noted. CONCLUSIONS: Continuous SPIP blockade did not demonstrate superiority over single-injection SPIP blockade in reducing acute sternal pain on coughing at 24 hours after cardiac surgery. TRIAL REGISTRATION NUMBER: NCT05054179.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Jen TTH, Prabhakar C, Matras PJ, et al. Analgesic efficacy of continuous superficial parasternal intercostal plane blockade in patients undergoing cardiac surgery with median sternotomy: a randomized controlled trial. Reg Anesth Pain Med. 2025. PMID: 41193383. doi:10.1136/rapm-2025-107162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。